» Articles » PMID: 28618859

Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy

Overview
Publisher Sage Publications
Date 2017 Jun 17
PMID 28618859
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although the contributions of sitagliptin to endothelial function in diabetes mellitus were previously reported, the potential mechanisms still remain undefined. Our research was intended to explore the underlying mechanisms of protective effects of sitagliptin treatment on endothelial dysfunction in Zucker diabetic fatty (ZDF) rats. Male lean nondiabetic Zucker rats were used as control and male obese ZDF rats were randomly divided into ZDF and ZDF + sitagliptin groups. The significant decrease in endothelium-dependent relaxation induced by acetylcholine was observed in mesenteric arteries and thoracic aorta rings of ZDF rats. The administration of sitagliptin restored the vascular function effectively. The morphology study showed severe endothelial injuries in thoracic aortas of ZDF rats, and sitagliptin treatment attenuated these changes. The increased malondialdehyde levels and decreased superoxide dismutase activities in serum of ZDF rats were reversed by sitagliptin treatment. Sitagliptin also increased the expression of endothelial nitric oxide synthase and microtubule-associated protein 1 light chain 3 (LC3) and decreased the expression of inducible nitric oxide synthase, 3-nitrotyrosine, and p62 in ZDF rats. After giving Fe (III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride porphyrin pentachloride (FeTMPyP, a peroxynitrite [ONOO] scavenger) or sitagliptin to high-glucose (30 mmol/L, 48 hours) cultured human umbilical vein endothelial cells (HUVECs), the increased levels of Beclin-1 and lysosome-associated membrane protein type 2 were detected. Both FeTMPyP and sitagliptin also significantly increased the number of mRFP-GFP-LC3 dots per cell, suggesting that autophagic flux was increased in HUVECs. Our study indicated that sitagliptin treatment can improve the endothelium-dependent relaxation and attenuate the endothelial impairment of ZDF rats. The protective effects of sitagliptin are possibly related to antiperoxynitrite and promoting autophagy.

Citing Articles

Vascular nitric oxide resistance in type 2 diabetes.

Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A Cell Death Dis. 2023; 14(7):410.

PMID: 37433795 PMC: 10336063. DOI: 10.1038/s41419-023-05935-5.


Enhanced Diabetic Wound Healing Using Electrospun Biocompatible PLGA-Based Saxagliptin Fibrous Membranes.

Lee C, Huang S, Hung K, Cho C, Liu S Nanomaterials (Basel). 2022; 12(21).

PMID: 36364516 PMC: 9659155. DOI: 10.3390/nano12213740.


Chronic Thoracic Aortic Dissection: How to Treat, When to Intervene.

Papakonstantinou P, Benia D, Polyzos D, Papakonstantinou K, Rorris F, Toulgaridis F Life (Basel). 2022; 12(10).

PMID: 36294947 PMC: 9605429. DOI: 10.3390/life12101511.


Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway.

Cao Q, Xu D, Chen Y, Long Y, Dai F, Gui L Front Pharmacol. 2021; 12:670389.

PMID: 34531738 PMC: 8438525. DOI: 10.3389/fphar.2021.670389.


Sitagliptin attenuates endothelial dysfunction independent of its blood glucose controlling effect.

Chang X, Xiao F, Pan Q, Wang X, Guo L Korean J Physiol Pharmacol. 2021; 25(5):425-437.

PMID: 34448460 PMC: 8405439. DOI: 10.4196/kjpp.2021.25.5.425.